"Retina Vitreous surgeons/physicians serving San Jose, Mountain View, San Mateo, Daly City and Monterey. Specializing in the research and treatment of Macular Degeneration, Diabetic Retinopathy, and other retinal disease."

During the past decade, Retina Vitreous Associates Medical Group Inc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Retina Vitreous Associates Medical Group Inc" are "Diabetic Macular Edema" (1 trials), "Macular Edema" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Retina Vitreous Associates Medical Group Inc" in a lesser frequency.

Most popular intervention types in "Retina Vitreous Associates Medical Group Inc" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "IVT Aflibercept" (1 trials), "Lucentis or Avastin" (1 trials), "SC CLS-TA" (1 trials), "suprachoroidal CLS-TA" (1 trials) and "suprachoroidal sham" (1 trials). Other intervention names were less common.

The vast majority of trials in "Retina Vitreous Associates Medical Group Inc" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Retina Vitreous Associates Medical Group Inc". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Retina Vitreous Associates Medical Group Inc, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Vitreous Associates Medical Group Inc, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".